Logo image of VRA

VERA BRADLEY INC (VRA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:VRA - US92335C1062 - Common Stock

2.68 USD
+0.21 (+8.5%)
Last: 11/21/2025, 8:04:53 PM
2.69 USD
+0.01 (+0.37%)
After Hours: 11/21/2025, 8:04:53 PM
Fundamental Rating

2

VRA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 46 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of VRA is average, but there are quite some concerns on its profitability. VRA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year VRA has reported negative net income.
VRA had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VRA reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: VRA reported negative operating cash flow in multiple years.
VRA Yearly Net Income VS EBIT VS OCF VS FCFVRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

The Return On Assets of VRA (-36.78%) is worse than 91.30% of its industry peers.
The Return On Equity of VRA (-69.69%) is worse than 86.96% of its industry peers.
Industry RankSector Rank
ROA -36.78%
ROE -69.69%
ROIC N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
VRA Yearly ROA, ROE, ROICVRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

VRA's Gross Margin of 48.45% is in line compared to the rest of the industry. VRA outperforms 52.17% of its industry peers.
In the last couple of years the Gross Margin of VRA has declined.
VRA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
VRA Yearly Profit, Operating, Gross MarginsVRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

4

2. Health

2.1 Basic Checks

VRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VRA has less shares outstanding
Compared to 5 years ago, VRA has less shares outstanding
VRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VRA Yearly Shares OutstandingVRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
VRA Yearly Total Debt VS Total AssetsVRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

VRA has an Altman-Z score of 2.25. This is not the best score and indicates that VRA is in the grey zone with still only limited risk for bankruptcy at the moment.
VRA has a worse Altman-Z score (2.25) than 65.22% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that VRA is not too dependend on debt financing.
The Debt to Equity ratio of VRA (0.07) is better than 82.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Altman-Z 2.25
ROIC/WACCN/A
WACC10.8%
VRA Yearly LT Debt VS Equity VS FCFVRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

VRA has a Current Ratio of 2.43. This indicates that VRA is financially healthy and has no problem in meeting its short term obligations.
VRA has a Current ratio of 2.43. This is in the better half of the industry: VRA outperforms 71.74% of its industry peers.
VRA has a Quick Ratio of 2.43. This is a bad value and indicates that VRA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.76, VRA is not doing good in the industry: 80.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 0.76
VRA Yearly Current Assets VS Current LiabilitesVRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

The earnings per share for VRA have decreased strongly by -531.82% in the last year.
VRA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.07%.
Measured over the past years, VRA shows a decrease in Revenue. The Revenue has been decreasing by -5.56% on average per year.
EPS 1Y (TTM)-531.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.38%
Revenue 1Y (TTM)-31.07%
Revenue growth 3Y-11.71%
Revenue growth 5Y-5.56%
Sales Q2Q%-36.06%

3.2 Future

The Earnings Per Share is expected to grow by 44.14% on average over the next years. This is a very strong growth
VRA is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -16.08% yearly.
EPS Next Y25.42%
EPS Next 2Y44.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-31.18%
Revenue Next 2Y-16.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VRA Yearly Revenue VS EstimatesVRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
VRA Yearly EPS VS EstimatesVRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VRA. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 53.07, the valuation of VRA can be described as expensive.
Based on the Price/Forward Earnings ratio, VRA is valued a bit more expensive than the industry average as 71.74% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.42, VRA is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 53.07
VRA Price Earnings VS Forward Price EarningsVRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VRA Per share dataVRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VRA does not grow enough to justify the current Price/Earnings ratio.
VRA's earnings are expected to grow with 44.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.14%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

VRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VERA BRADLEY INC

NASDAQ:VRA (11/21/2025, 8:04:53 PM)

After market: 2.69 +0.01 (+0.37%)

2.68

+0.21 (+8.5%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)09-11 2025-09-11/bmo
Earnings (Next)12-03 2025-12-03
Inst Owners60.46%
Inst Owner Change-21.07%
Ins Owners11.17%
Ins Owner Change9.51%
Market Cap74.88M
Revenue(TTM)303.05M
Net Income(TTM)-97.91M
Analysts45
Price Target5.61 (109.33%)
Short Float %6.66%
Short Ratio5.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-55.12%
Min EPS beat(2)-197.03%
Max EPS beat(2)86.8%
EPS beat(4)1
Avg EPS beat(4)-303.19%
Min EPS beat(4)-556.97%
Max EPS beat(4)86.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.51%
Min Revenue beat(2)-10.65%
Max Revenue beat(2)-4.37%
Revenue beat(4)0
Avg Revenue beat(4)-10.62%
Min Revenue beat(4)-19.17%
Max Revenue beat(4)-4.37%
Revenue beat(8)0
Avg Revenue beat(8)-9.22%
Revenue beat(12)2
Avg Revenue beat(12)-6.2%
Revenue beat(16)2
Avg Revenue beat(16)-6.01%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.33%
EPS NY rev (1m)0%
EPS NY rev (3m)23.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 53.07
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.53
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-0.95
EYN/A
EPS(NY)0.05
Fwd EY1.88%
FCF(TTM)-1.2
FCFYN/A
OCF(TTM)-0.87
OCFYN/A
SpS10.85
BVpS5.03
TBVpS5.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -36.78%
ROE -69.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.45%
FCFM N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
F-Score2
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -1703.83%
Cap/Sales 3.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.43
Quick Ratio 0.76
Altman-Z 2.25
F-Score2
WACC10.8%
ROIC/WACCN/A
Cap/Depr(3y)68.99%
Cap/Depr(5y)55.33%
Cap/Sales(3y)1.74%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-531.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.38%
EPS Next Y25.42%
EPS Next 2Y44.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.07%
Revenue growth 3Y-11.71%
Revenue growth 5Y-5.56%
Sales Q2Q%-36.06%
Revenue Next Year-31.18%
Revenue Next 2Y-16.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2307.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year0.87%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-238.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-181.65%
OCF growth 3YN/A
OCF growth 5YN/A

VERA BRADLEY INC / VRA FAQ

Can you provide the ChartMill fundamental rating for VERA BRADLEY INC?

ChartMill assigns a fundamental rating of 2 / 10 to VRA.


What is the valuation status for VRA stock?

ChartMill assigns a valuation rating of 1 / 10 to VERA BRADLEY INC (VRA). This can be considered as Overvalued.


How profitable is VERA BRADLEY INC (VRA) stock?

VERA BRADLEY INC (VRA) has a profitability rating of 1 / 10.


How sustainable is the dividend of VERA BRADLEY INC (VRA) stock?

The dividend rating of VERA BRADLEY INC (VRA) is 0 / 10 and the dividend payout ratio is 0%.